Artificial intelligence is attracting capital at a pace that often compresses analysis. For accredited investors, that creates a familiar problem: when a theme is compelling, valuations can move faster than fundamentals. Investing in artificial intelligence can be worthwhile, but only when the investment case is tied to durable economics, clear underwriting, and a realistic view of where value will actually accrue.
That distinction matters because AI is not a single asset class. It is a broad technology layer touching infrastructure, software, data, cybersecurity, health care, industrial operations, and financial services. Some businesses will benefit because they build the tools. Others will benefit because they apply those tools to improve margins, speed, or decision quality. Many more will claim exposure without developing a durable advantage.
In public conversation, AI is often treated as a monolith. In practice, investors are underwriting very different business models. A semiconductor company supplying compute capacity has different risk drivers than an enterprise software platform adding AI features. A private company building vertical workflow automation for logistics has a different path to value creation than a foundation model developer with large research costs and uncertain pricing power.
For that reason, investing in artificial intelligence starts with categorization. The first category is infrastructure: chips, cloud capacity, networking, power, and data center support. The second is enabling software: model tooling, data architecture, cybersecurity, and orchestration. The third is application-layer businesses using AI to solve a specific commercial problem, often inside a workflow where customers already have budget and urgency.
Each category can produce strong returns, but the risk profile changes materially. Infrastructure can benefit from powerful demand trends, yet it may also carry capital intensity, supply chain dependency, and cyclical pricing pressure. Enabling software can offer recurring revenue, though competition can compress margins if differentiation is weak. Application-layer businesses may show the cleanest commercial logic, but only if they deliver measurable outcomes that customers will continue paying for after the initial enthusiasm fades.
One of the most common mistakes in thematic investing is assuming that widespread adoption guarantees broad profitability. It does not. Markets can be right about a trend and wrong about who captures the economics.
In AI, value may concentrate in a narrower set of companies than headline coverage suggests. Firms with proprietary data, embedded customer relationships, and clear distribution advantages may be better positioned than businesses relying on generalized claims of innovation. The question is not simply whether AI usage grows. The more relevant question is whether a company can defend pricing, improve retention, or widen margins because of its AI capabilities.
This is where disciplined investors often separate narrative from investability. A company that reduces underwriting time, lowers fraud losses, or improves industrial maintenance schedules has a more tangible investment case than one promising broad disruption without evidence of customer adoption. Revenue quality matters. So do implementation cycles, switching costs, and the degree to which AI is mission-critical rather than experimental.
In private markets, this issue becomes even more important. Growth can appear impressive in early rounds, but if customer acquisition depends on unusually high sales effort or if product performance is not durable at scale, the valuation may outrun the actual business. Rigorous diligence should focus on repeatability, unit economics, concentration risk, and whether management is building a company or merely riding a category wave.
Not every attractive investment in the sector needs to be a pure AI company. In fact, some of the most resilient opportunities may come from businesses that use AI as an operational advantage rather than a marketing identity.
A software platform serving a specialized industry may improve customer retention through AI-enabled features while still deriving value from existing contracts, integration depth, and domain expertise. A health care services business may use AI to streamline documentation or resource planning, improving margins without changing the core model. These are often more understandable businesses because the AI component enhances an already valid economic engine.
That distinction can support better risk management. Companies whose entire valuation depends on uncertain future technical leadership may offer outsized upside, but they also carry substantial execution risk. Businesses with AI exposure, but not full AI dependence, may provide a more balanced profile for investors who prioritize downside awareness alongside growth.
Many investors focus first on whether the technology works. That matters, but valuation often presents the more immediate hazard. A very good company can still be a poor investment if entry price assumes years of perfect execution. In markets where AI enthusiasm is high, multiples can detach from normalized cash flow expectations or realistic exit scenarios.
Private investors should be especially careful with rounds priced on strategic excitement rather than disciplined comparables. If future capital raises become more selective, businesses with heavy burn and unclear monetization can face down rounds, dilution, or constrained strategic options.
Some AI products look differentiated early, then become harder to defend as models improve and tooling becomes more accessible. If a product advantage depends mainly on access to broadly available models, then the moat may reside elsewhere - in workflow integration, customer trust, compliance, or data ownership.
A disciplined underwriting process should ask what remains defensible if the underlying model becomes cheaper, faster, or more widely distributed. If the answer is not clear, long-term margin assumptions deserve skepticism.
As AI becomes more integrated into business decision-making, questions around privacy, explainability, intellectual property, and error liability become more material. This is particularly relevant in health care, finance, legal services, and sectors with sensitive data or regulated outcomes.
For investors, these are not abstract policy concerns. They affect adoption speed, compliance cost, contract structure, and reputation risk. A company operating in a regulated environment may still be attractive, but diligence should reflect the reality that commercialization can be slowed by governance requirements.
For investors considering direct exposure, the framework should remain familiar even if the technology is new. Start with the problem being solved. If the customer pain point is vague, the investment case is likely weak. Then assess whether AI is materially improving outcomes or merely enhancing presentation.
Next, examine the business model. Are revenues recurring? Is customer retention strong after deployment? Does implementation create switching costs? Can margins expand as the company scales, or will serving each customer remain labor-intensive despite the AI narrative?
Management quality remains central. Teams that combine technical competence with operating discipline are more likely to build enduring value than teams optimized primarily for fundraising momentum. Investors should also review data strategy, security controls, and the quality of customer references. In private deals, governance terms, reporting standards, and alignment between founders and investors are just as important as product vision.
For many accredited investors, indirect access may be the more prudent route. A professionally managed private vehicle, a diversified growth equity strategy, or selective exposure through companies with strong fundamentals can reduce single-asset risk. That approach may limit upside relative to a concentrated winner, but it can improve the probability of a more durable outcome.
AI should be viewed as one component of portfolio construction, not a complete strategy. Even if conviction is high, concentration risk remains real. For investors who prioritize capital preservation and income alongside growth, a measured allocation is usually more consistent with long-term objectives than chasing the most visible opportunity set.
This is where portfolio role matters. Venture and growth equity investments tied to AI may serve a return-seeking function, but they should be balanced against assets with different liquidity, duration, and cash flow profiles. Private credit, for example, can play a very different role in supporting income generation and downside protection. The point is not to avoid innovation. It is to place innovation in the context of the whole portfolio rather than treating it as a substitute for discipline.
At Covenant, that same principle applies across private markets: access matters, but structure, underwriting, and alignment matter more. The strongest outcomes usually come from pairing selective opportunity with a clear understanding of risk.
Artificial intelligence will likely shape the next decade of business operations and value creation. That does not mean every company in the space will justify its valuation, or that every investor should pursue the theme the same way. The better question is whether a given opportunity fits your standards for durability, transparency, and portfolio purpose. When those pieces are clear, enthusiasm becomes less relevant and judgment becomes more useful.